ubmslateNT-logo-ubm

NT Mobile Menu

Search form

Topics:

Multiple sclerosis

Multiple sclerosis

Three new studies explore preventing secondary stroke, a potential biomarker for MS prediction, and a link between vitamin D and headache.

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.

Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.